About the journal
Antimicrobial Agents and Chemotherapy is an open-access journal published by ASM in United States, publishing in english. It is listed in MEDLINE according to the sources read. Declared review time at DOAJ: 15 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- ASM
- ISSN
- 0066-4804 · 1098-6596
- Country
- United States
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 430
- Declared review time
- 15 weeks
- Declared peer-review model
- peer_review
- Official website
- https://journals.asm.org/journal/aac
Index listings
- MEDLINE · 1972-01-01
- Indexing
- MEDLINE
- APC
- —
- Declared review time (DOAJ)
- 15 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
430
Most recent article
last month
Average review time (journal-declared via DOAJ)
15weeks
Works in OpenAlex
33899
Last recorded publication year
2026
h-index
355
i10-index
28199
From OpenAlex open data (CC0).
Editorial & policy11
- Added to DOAJ
- 2026-08-18
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- Yes
- Declared digital preservation
- LOCKSSPMC
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2027
- Level 2 — top tier (~20% of the field's channels)
- Open references deposited at Crossref
- 97%
- ORCID iDs in current deposits
- 100%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- AAC
- Source type
- journal
- NLM unique ID (PubMed)
- 0315061
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- Antibiotic Resistance in Bacteria
- Antibiotic Resistance in Bacteria
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotics Pharmacokinetics and Efficacy
- Antimicrobial Resistance in Staphylococcus
- Antimicrobial Resistance in Staphylococcus
- Antifungal resistance and susceptibility
- Antifungal resistance and susceptibility
Show all subjects (50)
- Pneumonia and Respiratory Infections
- Pneumonia and Respiratory Infections
- Bacterial Identification and Susceptibility Testing
- Bacterial Identification and Susceptibility Testing
- HIV/AIDS drug development and treatment
- HIV/AIDS drug development and treatment
- Bacterial biofilms and quorum sensing
- Bacterial biofilms and quorum sensing
- Tuberculosis Research and Epidemiology
- Tuberculosis Research and Epidemiology
- Mycobacterium research and diagnosis
- Mycobacterium research and diagnosis
- Pneumocystis jirovecii pneumonia detection and treatment
- Pneumocystis jirovecii pneumonia detection and treatment
- HIV Research and Treatment
- HIV Research and Treatment
- Fungal Infections and Studies
- Fungal Infections and Studies
- Bacterial Genetics and Biotechnology
- Bacterial Genetics and Biotechnology
- Cancer therapeutics and mechanisms
- Cancer therapeutics and mechanisms
- Malaria Research and Control
- Malaria Research and Control
- Drug Transport and Resistance Mechanisms
- Drug Transport and Resistance Mechanisms
- Antimicrobial Peptides and Activities
- Antimicrobial Peptides and Activities
- Pharmaceutical and Antibiotic Environmental Impacts
- Pharmaceutical and Antibiotic Environmental Impacts
- Bacterial Infections and Vaccines
- Bacterial Infections and Vaccines
- Streptococcal Infections and Treatments
- Streptococcal Infections and Treatments
- Bacteriophages and microbial interactions
- Bacteriophages and microbial interactions
- Antibiotic Use and Resistance
- Antibiotic Use and Resistance
- Clostridium difficile and Clostridium perfringens research
- Clostridium difficile and Clostridium perfringens research
- Herpesvirus Infections and Treatments
- Herpesvirus Infections and Treatments
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ